ISO 14001:2026 - Environmental management systems — Requirements with guidance for use - Order now!

PRICES include / exclude VAT
>UNE standards>UNE EN 16939:2018 - Animal feeding stuffs: Methods of sampling and analysis - Detection of tylosin, spiramycin and virginiamycin - Thin Layer Chromatography and bioautography
in stockReleased: 2018-03-21
UNE EN 16939:2018 - Animal feeding stuffs: Methods of sampling and analysis - Detection of tylosin, spiramycin and virginiamycin - Thin Layer Chromatography and bioautography

UNE EN 16939:2018

Animal feeding stuffs: Methods of sampling and analysis - Detection of tylosin, spiramycin and virginiamycin - Thin Layer Chromatography and bioautography

Alimentos para animales: Métodos de muestreo y análisis. Detección de tilosina, espiramicina y virginiamicina. Cromatografía en capa fina y bioautografía.

Format
Availability
Price and currency
English PDF
Immediate download
Printable
103.53 USD
English Hardcopy
In stock
103.53 USD
Spanish PDF
Immediate download
Printable
103.53 USD
Spanish Hardcopy
In stock
103.53 USD
Standard number:UNE EN 16939:2018
Pages:29
Released:2018-03-21
Status:Standard
Pages (Spanish):32
DESCRIPTION

UNE EN 16939:2018

The method makes it possible to detect and identify spiramycin, tylosin and virginiamycin in animal feeding stuffs (feed raw materials of mainly plant origin and compound feeds) excluding mineral feeds and premixtures. The limit of detection is about 2 mg/kg for spiramycin, 1 mg/kg for tylosin and 1 mg/kg for virginiamycin. In some milk replacers, it can be slightly higher than 1 mg/kg for virginiamycin. Reported limits of detection are probably little overestimated but were fully validated during the collaborative study (see Annex B). In each laboratory, each day of analysis, spiked blank samples at 1 mg/kg for spiramycin and virginiamycin and at 0,5 mg/kg for tylosin are analysed for checking lower detection limits (see 9.2 and 9.3). These lower limits of detection are achievable, but should be established with an in-house validation first. Some other antibiotics may interfere in the detection of these 3 specific macrolide antibiotics. The known interferences are specified in Annex A of the method. That method should be used as a qualitative screening and/or a post-screening method (after microbiological plate test, for example). The follow-up of the antibiotics presence may be done by other analytical technics (LC and/or LC-MS technics) [4] [9]. For confirmatory purposes, LCMS is required.